Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | NC762 |
Synonyms | |
Therapy Description |
NC762 is a monoclonal antibody targeting VTCN1 (B7-H4), which potentially inhibits tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 319). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
NC762 | NC-762|NC 762 | NC762 is a monoclonal antibody targeting VTCN1 (B7-H4), which potentially inhibits tumor growth (Cancer Res 2021;81(13_Suppl):Abstract nr 319). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT04875806 | Phase Ib/II | NC762 | A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors | Terminated | USA | 0 |